Stevanato Group (NYSE:STVN) Director Sells €40,642.07 in Stock

Stevanato Group S.p.A. (NYSE:STVN) Director Luciano Santel sold 2,023 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of €20.09, for a total transaction of €40,642.07. Following the sale, the director directly owned 4,739 shares in the company, valued at €95,206.51. This trade represents a 29.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Stevanato Group Stock Up 0.1%

STVN stock opened at €21.27 on Thursday. The firm has a market cap of $6.44 billion, a PE ratio of 37.98, a P/E/G ratio of 1.76 and a beta of 0.77. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.08 and a current ratio of 1.61. The firm’s fifty day moving average is €18.93 and its 200 day moving average is €17.01. Stevanato Group S.p.A. has a one year low of €12.89 and a one year high of €28.00.

Institutional Trading of Stevanato Group

A number of institutional investors and hedge funds have recently modified their holdings of STVN. Conestoga Capital Advisors LLC raised its holdings in shares of Stevanato Group by 7.6% during the first quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock valued at $116,762,000 after acquiring an additional 602,050 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in shares of Stevanato Group by 10.4% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock worth $78,944,000 after acquiring an additional 368,792 shares during the last quarter. TimesSquare Capital Management LLC boosted its stake in shares of Stevanato Group by 7.1% in the fourth quarter. TimesSquare Capital Management LLC now owns 3,500,321 shares of the company’s stock worth $70,426,000 after acquiring an additional 232,645 shares during the last quarter. Bamco Inc. NY increased its position in shares of Stevanato Group by 1.4% during the fourth quarter. Bamco Inc. NY now owns 2,001,724 shares of the company’s stock worth $40,275,000 after purchasing an additional 27,965 shares in the last quarter. Finally, Jennison Associates LLC increased its position in shares of Stevanato Group by 13.7% during the fourth quarter. Jennison Associates LLC now owns 1,772,896 shares of the company’s stock worth $35,671,000 after purchasing an additional 213,602 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Wolfe Research began coverage on Stevanato Group in a report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price objective on the stock. Weiss Ratings raised Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 16th. Finally, TD Cowen upgraded Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Stevanato Group has a consensus rating of “Buy”.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.